Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss Web Desk March 24, 2026
Subscribe Email Subscribe By pressing the Subscribe button, you confirm that you have read our Privacy Policy. Latest News World News in Brief: Airstrikes continue in Ukraine, refugees return to DR Congo, emergency aid for the ‘Dry Corridor’ March 24, 2026 Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss March 24, 2026 March 24, 2026 Yango Tech launches Industrial AI Agents to accelerate UAE’s digital workforce agenda March 24, 2026 ‘Truly transformative’ new diagnostic tools can help end tuberculosis March 24, 2026 Sudan: Hospital strike highlights surge in drone attacks on civilians March 24, 2026 Your Ad Here Ad Size: 336x280 px Purchase Featured Categories
World News in Brief: Airstrikes continue in Ukraine, refugees return to DR Congo, emergency aid for the ‘Dry Corridor’ March 24, 2026
Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss March 24, 2026
